Consequently, a combination of ANO1 inhibitors such as niflumic acid and fluoxetine with cisplatin may prove effective in overcoming chemo-resistance in preclinical models of HNSCC. This evidence concerns the gene ANO1 and head and neck squamous cell carcinoma.